language English
AA

Altay, Ahmet

9 yayın · 108 atıf · 2021–2026

Yayın
9
Atıf
108
Yıllar
6
Yayınlar
Başlık Yıl Tip Atıf
Pro-oxidant effect of lobaric acid as a therapeutic strategy against breast cancer: a molecular perspective
MOLECULAR BIOLOGY REPORTS
2026 Article 0
Lobaric Acid Exhibits Anticancer Potential by Modulating the Wnt/β-Catenin Signaling Pathway in MCF-7 Cells
PHARMACOLOGY RESEARCH & PERSPECTIVES
2025 Article 1
Inhibition of thioredoxin reductase 1 by evernic and vulpinic acids: a promising anticancer strategy on A549 cells
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
2025 Article 2
Diffractaic acid exerts anti-cancer effects on hepatocellular carcinoma HepG2 cells by inducing apoptosis and suppressing migration through targeting thioredoxin reductase 1
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
2024 Article 9
Diffractaic acid exhibits thioredoxin reductase 1 inhibition in lung cancer A549 cells
JOURNAL OF APPLIED TOXICOLOGY
2023 Article 12
Effect of evernic acid on human breast cancer MCF-7 and MDA-MB-453 cell lines via thioredoxin reductase 1: A molecular approach
JOURNAL OF APPLIED TOXICOLOGY
2023 Article 16
Inhibition of thioredoxin reductase 1 by vulpinic acid suppresses the proliferation and migration of human breast carcinoma
LIFE SCIENCES
2022 Article 23
Diffractaic acid, a novel TrxR1 inhibitor, induces cytotoxicity, apoptosis, and antimigration in human breast cancer cells
CHEMICO-BIOLOGICAL INTERACTIONS
2022 Article 23
<i>In</i> <i>vitro</i> Antioxidant and Cytotoxic Activities of Extracts of Endemic <i>Tanacetum erzincanense</i> Together with Phenolic Content by LC-ESI-QTOF-MS
CHEMISTRY & BIODIVERSITY
2021 Article 22